The importance of enterovirus surveillance in a post-polio world

• Published in: The Lancet infectious diseases Vol. 22; no. 1; pp. e35 - e40
• Main Authors: Fischer, Thea K, Simmonds, Peter, Harvala, Heli
• Format: Journal Article
• Language: English
• Published: United States Elsevier Ltd 01.01.2022; Elsevier Limited
• Subjects: Biosafety; Central Nervous System Viral Diseases; Consortia; COVID-19; Diagnostic systems; Disabilities; Disease Outbreaks; Encephalitis; Enterovirus - pathogenicity; Enterovirus Infections - complications; Enterovirus Infections - epidemiology; Enteroviruses; Epidemics; Epidemiological Monitoring; Feces - virology; Humans; Infectious diseases; Laboratories; Meningitis; Myelitis; Neuromuscular Diseases; Paralysis; Paralysis - virology; Poliomyelitis - epidemiology; Poliovirus; Poliovirus - pathogenicity; Signs and symptoms; Viral diseases; Viruses; United States > US; Europe; Africa
• ISSN: 1473-3099; 1474-4457
• DOI: 10.1016/S1473-3099(20)30852-5

Poliovirus is known to most people in the world as the cause of polio, a devastating paralytic disease from the past. Success in polio eradication has understandably translated into stricter containment plans for poliovirus, coordinated by WHO. In this Personal View, we discuss the impact of recent biosafety level 3+ guidelines for handling potential poliovirus-containing diagnostic specimens, which has resulted in closure of many national WHO poliovirus reference laboratories. This reduction in laboratory capacity has a knock-on effect of capability to detect and characterise non-polio enteroviruses in samples obtained from patients with neurological symptoms. The development is of concern given the widespread circulation of non-polio enteroviruses, their role as the most common cause of meningitis worldwide, and their involvement in other severe neurological conditions, such as acute flaccid myelitis and encephalitis. These disease presentations have increased substantially in the past decade, and have been associated with major outbreaks of enterovirus D68 and enterovirus A71, leaving many who survived with lasting paralysis and disabilities. To address this growing gap in diagnostic and surveillance capability, we have established the European Non-Poliovirus Enterovirus Network (also known as ENPEN) as a supra-national, non-commercial, core reference consortium. Our consortium will develop, test, and implement generic surveillance platforms for non-polio enteroviruses and other emerging viral diseases.